Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000215944 | SCV000269296 | benign | not specified | 2015-09-16 | criteria provided, single submitter | clinical testing | p.Pro1025Pro in exon 18 of MYLK: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 1.1% (187/16510) of South Asian chromosomes including 4 homozygous individuals by the Exome Aggre gation Consortium (ExAC, http://exac.broadinstitute.org/; dbSNP rs144885184). |
Prevention |
RCV000215944 | SCV000315283 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000475139 | SCV000560696 | benign | Aortic aneurysm, familial thoracic 7 | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000215944 | SCV000717482 | benign | not specified | 2017-07-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV001170122 | SCV001332663 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-11-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000215944 | SCV001623303 | benign | not specified | 2021-04-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812224 | SCV002049121 | benign | not provided | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001170122 | SCV002606796 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-06-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002485375 | SCV002802210 | benign | Aortic aneurysm, familial thoracic 7; Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | 2021-07-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001812224 | SCV005075113 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | MYLK: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV001812224 | SCV005303597 | benign | not provided | criteria provided, single submitter | not provided |